Xu Huji

[Expert Profile] Xu Huji, Chief Physician, Professor, Doctoral Supervisor, is an authoritative expert in refractory lupus erythematosus in China, working in the Department of Rheumatology, Changzheng Hospital, Naval Medical University. He has long been dedicated to the clinical diagnosis, treatment, and translational research of refractory lupus erythematosus and multi-organ damage from lupus, and is an important expert in rheumatology in China.

[Education & Career] Professor Xu Huji graduated from a military medical university, completed systematic clinical training at Shanghai Changzheng Hospital, and further studied at famous international rheumatology centers, systematically mastering cutting-edge rheumatic disease diagnosis, treatment, and research methods. He has long served as Director of the Rheumatology Department at Shanghai Changzheng Hospital, holding academic positions including standing committee member of the Rheumatology Branch of the Chinese Medical Association. He has presided over grants from the National Natural Science Foundation of China and key military research projects, accumulating profound academic achievements in the fields of lupus and immunotherapy.

[Areas of Expertise] Professor Xu specializes in comprehensive treatment of refractory systemic lupus erythematosus, standardized management of lupus nephritis, lupus encephalopathy, and other multi-organ damage from lupus, as well as the diagnosis and treatment of various rheumatic diseases such as rheumatoid arthritis and Sjogren's syndrome. He is proficient in combination immunosuppressive regimens and novel immunotherapies such as biologics and CAR-T cell therapy for refractory lupus. He excels at managing "critical lupus patients who fail conventional treatment and experience repeated worsening," helping numerous patients turn their conditions around and preserve important organ function.

[Academic Achievements & Industry Contributions] Professor Xu has conducted cutting-edge research in the fields of refractory lupus erythematosus and novel immunotherapy, actively exploring the application of CAR-T and other cell therapies in autoimmune diseases. His innovative findings have been published in authoritative domestic and international journals, opening new directions for autoimmune disease treatment. He has participated in the development of Chinese lupus diagnosis and treatment guidelines and expert consensus statements, actively promoted multidisciplinary collaborative diagnosis and treatment and novel therapy clinical research for refractory lupus, and made pioneering contributions to improving the treatment level of refractory lupus erythematosus in China.

[Clinical Practice & Outstanding Contributions] For decades on the clinical front lines, Professor Xu has treated tens of thousands of patients with systemic lupus erythematosus and various difficult rheumatic diseases, including many refractory patients who traveled across multiple regions with critical conditions. Leading his team, he has successfully treated many severe lupus patients who were "given up as hopeless," creating miracles. He has received multiple military and national honors and awards, and is deeply trusted by patients and respected by peers alike. He is an outstanding expert in the field of refractory lupus erythematosus.

[Honors & Reputation] Professor Xu Huji serves as Director of the Rheumatology Department at Shanghai Changzheng Hospital and a standing committee member of the Rheumatology Branch of the Chinese Medical Association, among other academic positions. He has presided over national-level projects including key grants from the National Natural Science Foundation of China, and is an important expert in the field of rheumatology in China. He has profound expertise in precise diagnosis and immunotherapy of refractory lupus erythematosus and multi-organ lupus damage. He has led innovative treatment research for refractory lupus, promoted standardized application of biologics and cellular immunotherapy, and has research findings published in authoritative domestic and international journals. For decades on the clinical front lines, he has helped numerous severe lupus patients control their conditions and preserve organ function, trained a large number of rheumatology professionals, and is deeply trusted by patients and respected by peers alike.